Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Lucid Diagnostics Community
NasdaqCM:LUCD Community
1
Narratives
written by author
0
Comments
on narratives written by author
5
Fair Values set
on narratives written by author
Create a narrative
Lucid Diagnostics
Popular
Undervalued
Overvalued
Community Investing Ideas
Lucid Diagnostics
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Expanded Reimbursement And Cash-Pay Programs Will Open Future Markets
Key Takeaways Expanding reimbursement coverage and leveraging NCCN guidelines are strategies expected to enhance revenue and credibility with payers. New sales strategies and NIH grant could significantly boost revenue, with potential market expansion and direct contracts increasing financial stability.
View narrative
US$3.67
FV
67.3% undervalued
intrinsic discount
140.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
LUCD
LUCD
Lucid Diagnostics
Your Fair Value
US$
Current Price
US$1.20
160.9% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-64m
26m
2015
2018
2021
2024
2025
2027
2030
Revenue US$25.6m
Earnings US$3.7m
Advanced
Set Fair Value